Dose-Finding Designs for Early-Phase Cancer Clinical Trials
A Brief Guidebook to Theory and Practice
(Sprache: Englisch)
This book provides a comprehensive introduction to statistical methods for designing early phase dose-finding clinical trials. It will serve as a textbook or handbook for graduate students and practitioners in biostatistics and clinical investigators who...
Voraussichtlich lieferbar in 3 Tag(en)
versandkostenfrei
Buch (Kartoniert)
Fr. 71.00
inkl. MwSt.
- Kreditkarte, Paypal, Rechnungskauf
- 30 Tage Widerrufsrecht
Produktdetails
Produktinformationen zu „Dose-Finding Designs for Early-Phase Cancer Clinical Trials “
Klappentext zu „Dose-Finding Designs for Early-Phase Cancer Clinical Trials “
This book provides a comprehensive introduction to statistical methods for designing early phase dose-finding clinical trials. It will serve as a textbook or handbook for graduate students and practitioners in biostatistics and clinical investigators who are involved in designing, conducting, monitoring, and analyzing dose-finding trials. The book will also provide an overview of advanced topics and discussions in this field for the benefit of researchers in biostatistics and statistical science. Beginning with backgrounds and fundamental notions on dose finding in early phase clinical trials, the book then provides traditional and recent dose-finding designs of phase I trials for, e.g., cytotoxic agents in oncology, to evaluate toxicity outcome. Included are rule-based and model-based designs, such as 3 + 3 designs, accelerated titration designs, toxicity probability interval designs, continual reassessment method and related designs, and escalation overdose control designs. This bookalso covers more complex and updated dose-finding designs of phase I-II and I/II trials for cytotoxic agents, and cytostatic agents, focusing on both toxicity and efficacy outcomes, such as designs with covariates and drug combinations, maximum tolerated dose-schedule finding designs, and so on.Inhaltsverzeichnis zu „Dose-Finding Designs for Early-Phase Cancer Clinical Trials “
1. Introduction.- 2. Dose Finding in Early Phase Clinical Trials.- 3. Rule.- Based Designs.- 4. Continual Reassessment Method Designs.- 5. Escalation with Overdose Control Designs.- 6. Decision.- Theoretic Designs.- 7. Complex Designs.Autoren-Porträt von Takashi Daimon, Akihiro Hirakawa, Shigeyuki Matsui
Takashi Daimon, Department of Biostatistics, Hyogo College of Medicine- Akihiro Hirakawa, Center for Advanced Medicine and Clinical Research, Nagoya University Graduate School of Medicine- Shigeyuki Matsui, Department of Biostatistics, Nagoya University Graduate School of Medicine
Bibliographische Angaben
- Autoren: Takashi Daimon , Akihiro Hirakawa , Shigeyuki Matsui
- 2019, 1st ed. 2019, XV, 133 Seiten, 3 farbige Abbildungen, Masse: 15,5 x 23,5 cm, Kartoniert (TB), Englisch
- Verlag: Springer, Berlin
- ISBN-10: 4431555846
- ISBN-13: 9784431555841
- Erscheinungsdatum: 15.07.2019
Sprache:
Englisch
Pressezitat
"The book under review is intended to serve as a brief handbook for graduate students and biostatistics, as well as for oncologists who are involved in the analysis of methods for developing optimal doses for treating cancer in the early stages." (Fatima T. Adylova, zbMATH 1427.92001, 2020)
Kommentar zu "Dose-Finding Designs for Early-Phase Cancer Clinical Trials"
0 Gebrauchte Artikel zu „Dose-Finding Designs for Early-Phase Cancer Clinical Trials“
Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
---|
Schreiben Sie einen Kommentar zu "Dose-Finding Designs for Early-Phase Cancer Clinical Trials".
Kommentar verfassen